Method for processing checks prior to electronic deposit

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Pitney Bowes Inc. patent solves the following problem:

Traditionally, the business deposited checks received from, for example, the customer physically by taking them to a branch of their bank and put them on the counter with a teller or dropping them into a night deposit box. The actual physical presentation of checks to hide because, under the banking law, the depository bank to present the original of each check to the corresponding payment in the bank to clear the check. This changed in October 2004 with the construction of The Check Clearing for the 21st Century Act, commonly referred to as Check 21. Check 21 took the legal requirement that an original paper check to be presented to claims payment. Instead, the banks now use digital images to bring checks data from the bank of first deposit to pay the bank. Therefore, depositors have the option to put checks electronically. In particular, when a depositor would put one or more checks, an operator, the accounts receivable clerk, can scan each paper checks put to use some sort of a digital scanner to create an image of each check. The checks are then transmitted electronically to the bank for the first deposit. If any low bank, paying bank, not processing a check image, the image will be printed, according to certain specifications, to make what is known as a substitute checks, which are legal the equivalent of the original paper check. Check 21 thus opened the door for remote check deposit solutions where check images, the original paper checks, used to make deposits, so that business thereby eliminating trips to the bank. Furthermore, the use of check images reduces check transportation costs to banks and improves funds availability.

Our analysis of this patent is as follows:

Pitney Bowes Inc.’s patent US 7609873 B2 deals with Method for processing checks prior to electronic deposit.
A method of processing checks include obtaining the first information on the checks that compiled an operator to use a calculator, such as scanning a calculator tape, wherein the first information includes a first number of the first amount of dollars, each of which corresponds to a respective one of the checks. method further includes scanning checks to make one more check, claims the pictures to check a second number of the second amount of dollars, each equivalent to one portion jail one of these checks, determine if the first number is equal to the second number, and give a wrong signal if the first number does not equal the second number (which is an indication that a misfeed occurred).

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Pharmaceutical composition

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Cpex Pharmaceuticals, Inc. patent solves the following problem:

Our analysis of this patent is as follows:

Cpex Pharmaceuticals, Inc.’s patent US 7608610 B2 deals with Pharmaceutical composition.
A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed in US Pat. No. 5,023,252 Hsieh; and (C) a thickening agent; including, for example, a composition of cyclic enhancer is a macrocyclic ester or a macrocyclic ketone; using the composition to treat a condition, for example, male hypogonadism, in a patient by applying the composition of the membrane of the patient; and a method of making the composition.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Bariatric sleeve

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Gi Dynamics, Inc. patent solves the following problem:

According to the Center for Disease Control (CDC), more than sixty percent of the population in the United States are overweight, and almost twenty percent of the obese. This translated into 38.8 million adults in the United States with a Body Mass Index (BMI) of 30 or over. The BMI is defined as weight of a man (in kilograms) divided by height (in meters), play. To be considered clinically, morbidly obese, one must meet one of three criteria: BMI over 35, 100 lbs. Overweight or 100% above ideal weight of the body. There is also a category for the super-obese for those weighing over 350 lbs.

Our analysis of this patent is as follows:

Gi Dynamics, Inc.’s patent US 7608114 B2 deals with Bariatric sleeve.
Methods and apparatus for limiting absorption of food products to certain parts of the digestive system was presented. A stomach implant device anchored in the stomach and extends beyond the ligament of Treitz. All meat pierced belly funneled through the device. The belly device includes an anchor for the foundation of the devices in the stomach and a flexible sleeve. When implanted in the intestine, the arm can limit the absorption of nutrients, delay in mixing the chyme with digestive enzymes, hormonal time, to give negative feedback, and combinations thereof. anchor is collapsible for endoscopic delivery and removal.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Process for enhancing the solubility of poorly soluble drugs

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Exxpharma, LLC patent solves the following problem:

It is estimated that 40% of drug candidates fail to progress through the clinical process of drug development because of poor solubility, poor permeability or both. In an attempt to overcome solubility issues, pharmaceutical scientists exploring the many technologies, some of which led to considerable success. Some manufacturing processes commonly used to increase the dissolution rates and to improve the solubility of poorly soluble drugs include particle size reduction, crystal modification, co-crystal, polymeric entrapment and filling of liquid and semi-solid drug formulation in soft and hard gelatin capsules. All of these commonly used processes, however, have serious limitations. Some of these process labor intensive, pose serious challenges at the scale and / or use of costly equipment / process, which renders them of limited use when production costs were. The others are in general associated with significant strength drug product or environmental issues. It is obvious, therefore, that a cost-effective manufacturing process and composition to overcome the limitations of the prior art is lacking, and is the subject of the present invention.

Our analysis of this patent is as follows:

Exxpharma, LLC’s patent US 7607596 B1 deals with Process for enhancing the solubility of poorly soluble drugs.
The solubility / dissolution rate of a poorly soluble drug is developed through a process that uses a twin-screw extruder containing (i) a feed zone containing a first liquid and powder feed stations; (Ii) a recovery / mixing zone containing a second liquid feed port located in an upper part of the zone; (Iii) a granulation zone containing a second powder feed station located in an upper part of the zone and a third liquid feed port located on a lower part of the zone; and (iv) a wet zone.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Secreted proteins

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Incyte Corporation patent solves the following problem:

Protein transport and secretion is necessary for cellular function. Transport protein mediated a signal peptide located at amino terminal protein dad or hidden. The signal peptide consists of ten to twenty hydrophobic amino acids that target the nascent protein from ribosome to a particular membrane bound compartment such as the endoplasmic reticulum (ER). Protein target the ER to continue by way secretory or stay in any of the secretory organelles such as the ER, Golgi apparatus, or lysosomes. Proteins that transit through the secretory way be secreted into the extracellular space or left in the plasma membrane. Protein retained in the plasma membrane includes one or more transmembrane domains, each consisting of 20 hydrophobic amino acid residues. Secreted protein normally synthesized as inactive precursors because of the post-translation processing events during transit through the secretory way. Such events include glycosylation, proteolysis, and removal of the signal peptide with a signal peptidase. The other events that occur during the transport proteins include chaperone-dependent expression and folding of nascent proteins and protein interaction with a receptor or pore complex. Examples of secreted proteins with amino terminal signal peptide described below and include protein with an important role in cell-to-cell signaling. Such proteins include transmembrane receptor and cell surface markers, extracellular matrix molecules, cytokines, hormones, growth and diversity factor, enzyme, neuropeptides, vasomediators, cell surface markers, and antigen recognition molecules. (Reviewed in Alberts, B. et al. (1994) Molecular Biology of the Cell, garland Publishing, New York, NY, pp. 557-560, 582-592.)

Our analysis of this patent is as follows:

Incyte Corporation’s patent US 7608704 B2 deals with Secreted proteins.
human invention provides secreted protein (SECP) and polynucleotides which identify and encode SECP. invention also provides expression vector, host cells, antibodies, agonists and antagonists. invention also provides methods for diagnosing, treating, or preventing diseases associated with aberrant expression of SECP.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Treatment of infection in animals

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Mars, Inc. patent solves the following problem:

This application is the US National Stage of International Application No. PCT / GB01 / 01036, filed on March 9, 2001. This application further claims foreign priority PCT / Mb00 / 00890 filed on March 10, 2000, United Kingdom Using 0012401.6 filed May 22, 2000, and United Kingdom Using 0022210.9 filed on Aug. 11, 2000.

Our analysis of this patent is as follows:

Mars, Inc.’s patent US 7608291 B2 deals with Treatment of infection in animals.
The present invention relates to the use of a non-digestible carbohydrate in the form of a composition for treating or preventing pathogenic bacteria in the large intestine of a pet. It also provides a method for the prevention or treatment of a pathogenic bacteria in the large intestine of a pet, the method comprising administering said pet animal a composition comprising a non- digestible carbohydrate.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method for producing hydroxylammonium salts

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Domo Caproleuna Gmbh patent solves the following problem:

The invention relates to a method of making hydroxylammonium salts in catalytic reduction of nitrogen monoxide with hydrogen in a diluted aqueous solution of mineral acid in the presence of platinum catalysts suspended in a support in many subsequent reaction round .

Our analysis of this patent is as follows:

Domo Caproleuna Gmbh’s patent US 7608236 B2 deals with Method for producing hydroxylammonium salts.
One way to make hydroxylammonium salts in catalytic reaction of nitrogen monoxide with hydrogen in a diluted aqueous solution of mineral acid in the presence of platinum catalysts suspended in a support in many subsequent reaction stages. This reaction occurs in a stirred reactor in which a gas inlet and distribution system is given at the bottom of the stirred reactor, a disk misleading placed immediately upon the birth center or face support and more angled, concave and tilted misleading blades that rotate their angled or concave sides in the direction of movement, and a two-edged misleading given the misleading shaft in the upper part of the stirred reactor, the individual leaves offset like lamellas that they always wet the reactor cap when rotating.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Protein hydrolysates enriched in peptides having a carboxy terminal proline residue

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Dsm Ip Assets B.V. patent solves the following problem:

Enzyme hydrolysates of cow's milk or pieces of cow's milk only limited application in the food industry. Nevertheless, these hydrolysates occupy interesting wall space in the market, as evidenced by the large number of literature describing and claiming optimized processes for obtaining such hydrolysates. Milk or milk fractions were subjected to enzymes with proteolytic activity to produce the hydrolysates primarily to minimize the allergenicity of the product, abdominal facilitate uptake by offering an easily absorbed thinking, and to strengthen the protein acid products against precipitation during prolonged periods of storage.

Our analysis of this patent is as follows:

Dsm Ip Assets B.V.’s patent US 7608697 B2 deals with Protein hydrolysates enriched in peptides having a carboxy terminal proline residue.
One way to enzymatically producing a protein hydrolyzate from a protein substrate is described, wherein a proline-specific endoprotease or a composition containing a proline-specific endoprotease and optionally one or subtilisin a metallo endoprotease, and other enzymes like the carboxypeptidases, used to make a protein hydrolyzate peptide fractions enriched with a carboxy terminal proline residue. The protein hydrolysates can be used as or to reduce the bitterness eat nutritionally supplemented with protein hydrolysates, as well as creating hydrolyzate containing foods with low antigenicity.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Cash dispensing automated banking machine with improved unauthorized observation prevention capabilities

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Diebold Self-Service Systems Division Of Diebold, Incorporated patent solves the following problem:

The common type of automated banking machine used by consumers is an automated teller machine (ATM). ATMs enable customers to carry out banking transactions. Banking transactions carried out using the ATM may include sharing the cash, make deposits, transfer funds between accounts and account balance inquiries. The types of banking transactions a customer can carry out determined the capabilities of the particular banking machine and the programming of the institution operate the machine.

Our analysis of this patent is as follows:

Diebold Self-Service Systems Division Of Diebold, Incorporated’s patent US 7600672 B2 deals with Cash dispensing automated banking machine with improved unauthorized observation prevention capabilities.
An automated banking machine (10) includes a user interface (15). The automated banking machine (10) may include a secret device (350) position on the fascia to limit the viewing of the inputs made by a user input device such as a keypad (18).

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Processor for a passive ranger

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Fisher Daniel E patent solves the following problem:

The present invention relates to a processor for an angle interferometer and passive ranger.

Our analysis of this patent is as follows:

Fisher Daniel E’s patent US 7599678 B2 deals with Processor for a passive ranger.
A receiver includes an RF bridges and a processor coupled to the RF bridge to receive a signal from the RF bridge. The processor includes a clock source and a front end processor. The front end processor includes first and second source frequency, a processor on the converter and an analog to digital converter. The first source frequency of a reference signal based on a signal from the clock source. The reference signal with the RF bridge. The second source frequency of a first local oscillator signal based on the signal from the clock source. The processor on the converter heterodynes the first local oscillator signal and the information signal. Analog to digital converter coupled to the converter and processor provides a digital signal converted.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.